chr16-84170124-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_178452.6(DNAAF1):​c.1296G>C​(p.Glu432Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0876 in 1,605,926 control chromosomes in the GnomAD database, including 7,175 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E432K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.079 ( 514 hom., cov: 32)
Exomes 𝑓: 0.088 ( 6661 hom. )

Consequence

DNAAF1
NM_178452.6 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.933

Publications

19 publications found
Variant links:
Genes affected
DNAAF1 (HGNC:30539): (dynein axonemal assembly factor 1) The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNAAF1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 13
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00406757).
BP6
Variant 16-84170124-G-C is Benign according to our data. Variant chr16-84170124-G-C is described in ClinVar as [Benign]. Clinvar id is 226573.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.189 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF1NM_178452.6 linkc.1296G>C p.Glu432Asp missense_variant Exon 8 of 12 ENST00000378553.10 NP_848547.4 Q8NEP3-1A0A140VJN4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAAF1ENST00000378553.10 linkc.1296G>C p.Glu432Asp missense_variant Exon 8 of 12 1 NM_178452.6 ENSP00000367815.5 Q8NEP3-1

Frequencies

GnomAD3 genomes
AF:
0.0790
AC:
11995
AN:
151784
Hom.:
512
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0572
Gnomad AMI
AF:
0.131
Gnomad AMR
AF:
0.0587
Gnomad ASJ
AF:
0.103
Gnomad EAS
AF:
0.139
Gnomad SAS
AF:
0.198
Gnomad FIN
AF:
0.0707
Gnomad MID
AF:
0.0764
Gnomad NFE
AF:
0.0830
Gnomad OTH
AF:
0.0891
GnomAD2 exomes
AF:
0.0945
AC:
23744
AN:
251252
AF XY:
0.101
show subpopulations
Gnomad AFR exome
AF:
0.0577
Gnomad AMR exome
AF:
0.0439
Gnomad ASJ exome
AF:
0.104
Gnomad EAS exome
AF:
0.123
Gnomad FIN exome
AF:
0.0752
Gnomad NFE exome
AF:
0.0836
Gnomad OTH exome
AF:
0.0923
GnomAD4 exome
AF:
0.0885
AC:
128618
AN:
1454026
Hom.:
6661
Cov.:
100
AF XY:
0.0924
AC XY:
66852
AN XY:
723348
show subpopulations
African (AFR)
AF:
0.0556
AC:
1852
AN:
33296
American (AMR)
AF:
0.0464
AC:
2054
AN:
44266
Ashkenazi Jewish (ASJ)
AF:
0.106
AC:
2739
AN:
25782
East Asian (EAS)
AF:
0.152
AC:
5998
AN:
39566
South Asian (SAS)
AF:
0.202
AC:
17431
AN:
86104
European-Finnish (FIN)
AF:
0.0748
AC:
3989
AN:
53308
Middle Eastern (MID)
AF:
0.0824
AC:
460
AN:
5580
European-Non Finnish (NFE)
AF:
0.0798
AC:
88325
AN:
1106180
Other (OTH)
AF:
0.0963
AC:
5770
AN:
59944
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
8871
17742
26613
35484
44355
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3294
6588
9882
13176
16470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0791
AC:
12014
AN:
151900
Hom.:
514
Cov.:
32
AF XY:
0.0809
AC XY:
6009
AN XY:
74244
show subpopulations
African (AFR)
AF:
0.0574
AC:
2377
AN:
41428
American (AMR)
AF:
0.0586
AC:
895
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
356
AN:
3466
East Asian (EAS)
AF:
0.138
AC:
712
AN:
5146
South Asian (SAS)
AF:
0.199
AC:
953
AN:
4788
European-Finnish (FIN)
AF:
0.0707
AC:
747
AN:
10560
Middle Eastern (MID)
AF:
0.0753
AC:
22
AN:
292
European-Non Finnish (NFE)
AF:
0.0830
AC:
5639
AN:
67928
Other (OTH)
AF:
0.0919
AC:
194
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
534
1067
1601
2134
2668
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0701
Hom.:
167
Bravo
AF:
0.0756
TwinsUK
AF:
0.0863
AC:
320
ALSPAC
AF:
0.0786
AC:
303
ESP6500AA
AF:
0.0559
AC:
246
ESP6500EA
AF:
0.0844
AC:
726
ExAC
AF:
0.0971
AC:
11783
Asia WGS
AF:
0.183
AC:
636
AN:
3478
EpiCase
AF:
0.0863
EpiControl
AF:
0.0859

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 12, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Glu432Asp in exon 8 of DNAAF1: This variant is not expected to have clinical s ignificance because it has been identified in 20% (3315/16512) of South Asian ch romosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs9972733). -

Primary ciliary dyskinesia 13 Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 11, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 18, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.80
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.58
DANN
Benign
0.76
DEOGEN2
Benign
0.0057
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.0053
N
LIST_S2
Benign
0.50
T
MetaRNN
Benign
0.0041
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.3
L
PhyloP100
-0.93
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.63
N
REVEL
Benign
0.019
Sift
Benign
0.099
T
Sift4G
Benign
0.61
T
Polyphen
0.0
B
Vest4
0.022
MutPred
0.11
Loss of methylation at K430 (P = 0.0922);
MPC
0.019
ClinPred
0.0057
T
GERP RS
0.70
Varity_R
0.084
gMVP
0.075
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9972733; hg19: chr16-84203730; COSMIC: COSV57578659; COSMIC: COSV57578659; API